Top Bristol Myers Squibb Dealmaker Elizabeth Mily Is Leaving

Bristol Myers Squibb Co.’s top dealmaker Elizabeth Mily is leaving the US drugmaker.

Mily will depart the New York-based company and a search for her replacement has begun, a spokesperson for Bristol Myers confirmed in response to Bloomberg News queries. She had been executive vice president for strategy and business development after joining Bristol Myers in 2020, according to her LinkedIn profile.

Mily worked on deals including mergers and acquisitions, partnerships and drug licensing agreements. She was also a member of the company’s leadership team and used to report to former chief executive officer Giovanni Caforio.

“We ...